Categories
Featured Investing Stock Market News Stock Market Today

Top Stock Market News For Today July 14, 2022

Stock index futures edge downwards as investors consider the latest consumer price hikes.

Stock Market Futures Inch Lower Ahead Of Major Bank Earnings

U.S. stock futures are marginally lower in early morning trading on Thursday this week. Overall, this could be the result of the U.S. Bureau of Labor Statistics’s latest release on consumer prices. Throughout June 2022, the Consumer Price Index (CPI) is now showing a year-over-year gain of 9.1%. In other words, prices for a large array of consumer goods continue to swell as inflation holds at decades-high levels. To compare, the current 9.1% increase is above consensus Dow Jones economist estimates of 8.8%. This would mark the fastest pace of acceleration for the CPI since November 1981.

Commenting on the current state of things now is Michael Pearce, a senior U.S. economist at Capital Economics. He starts by saying, “Overall, this report confirms that the Fed will need to hike by 75bp again at the end-July meeting.” Pearce continues, “While some will draw parallels with the shockingly bad May CPI report, the backdrop is markedly different — commodity prices have fallen sharply and we’ve seen clearer signs of an economic slowdown, both of which will contribute to weaker price pressures ahead.” While you digest all this mixed data on the economy, here is how the major U.S. stock indexes are doing now. As of 5:27 a.m. ET, the Dow, S&P 500, and Nasdaq futures are trading lower by 1.11%, 1.21%, and 1.09% respectively.

Netflix Teams Up With Microsoft Via Ad-Supported Streaming Plan

Making headlines in the tech world today would be Netflix (NASDAQ: NFLX) and Microsoft (NASDAQ: MSFT). For the most part, this would be thanks to the latest collaboration between the two. To explain, Netflix is focusing on offering a more affordable version of its streaming service to consumers. After all, as inflation runs rampant, this would cater to a wider range of potential subscribers. To do this, Netflix is planning to offer a cheaper streaming plan with the integration of ads. Namely, the latest update on this front would be that Netflix is teaming up with Microsoft to accomplish this.

Explaining all this in further detail is Netflix COO Greg Peters. He writes, “Microsoft has the proven ability to support all our needs as we together build a new ad-supported offering. More importantly, Microsoft offered the flexibility to innovate over time on both the technology and sales side, as well as strong privacy protections for our members.” In the larger scheme of things, such a move would be timely for Netflix. As the streaming goliath continues to face issues with a shrinking subscriber base, this could be the case. All in all, this could put both NFLX stock and MSFT stock on investors’ radars ahead of today’s opening bell.

Source: TradingView

[Read More] Good Stocks To Buy Right Now? 3 Consumer Discretionary Stocks In Focus

Novavax Receives FDA Authorization For Covid Vaccine Use In Adults Ages 18 And Above

On the health care front, Novavax (NASDAQ: NVAX) is making a splash on the regulatory side of things. Notably, the company’s two-dose coronavirus vaccine now has emergency use authorization from the Food and Drug Administration (FDA). This would make it the first new shot to receive this regulatory green light in over a year. As it stands, the current approval is for use in adults ages 18 and over. Accordingly, this update comes just weeks after the FDA’s committee of independent experts unanimously recommended Novavax’s vaccine. Following this, Novavax will now need one last approval from the Centers for Disease Control and Prevention (CDC). With this in hand, pharmacies and general health care providers can begin the distribution of Novavax’s shot.

Elaborating on the importance of this regulatory update is Novavax CEO Stanley Erck. He begins by stating, “Today’s FDA emergency use authorization of our COVID-19 vaccine provides the U.S. with access to the first protein-based COVID-19 vaccine.” Erck adds, “This authorization reflects the strength of our COVID-19 vaccine’s efficacy and safety data, and it underscores the critical need to offer another vaccine option for the U.S. population while the pandemic continues.” Simply put, Novavax’s vaccine development tech is among the more conventional means of making vaccines. The likes of which have been and still are in use for creating shots catering to hepatitis B and HPV.

As U.S. officials push for another round of booster doses, Novavax’s offerings could appeal to individuals that remain doubtful about the latest mRNA shots from Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). After considering all this, NVAX stock could be worth keeping an eye on right now.

Source: TradingView

[Read More] Recession-Proof Stocks To Invest In Now? 3 E-commerce Stocks To Watch

Warren Buffett Ups Stake In Occidental Petroleum To Almost 20% Following Latest Investments

In other news, Warren Buffett remains steadfast on his mission to bet on Occidental Petroleum (NYSE: OXY). Evidently, according to the latest SEC filing, Berkshire Hathaway (NYSE: BRK.A) has bought another 4.3 million shares of Occidental this week. In detail, this was done via several transactions. Also in the filing, Berkshire’s purchase price for the shares ranges from between $56.11 to $59.93. Through its latest round of investments in OXY stock, Berkshire now owns 179.4 million shares.

For a sense of scale, they are worth about $10.4 billion, bringing Buffett’s stake up to a whopping 19.2%. Not to mention, Buffett’s firm also owns nearly $10 billion in Occidental preferred stock and has warrants to add another 83.9 million shares. Notably, OXY stock is now up by over 80% year-to-date, outpacing the broader stock market substantially. As a result, it could once again be in focus amongst its energy industry peers in the stock market today.

Source: TradingView

[Read More] Best Dividend Stocks To Buy In 2022? 5 To Watch Right Now

Tesla’s Head Of AI And Autopilot Andrej Karpathy Departs Following Sabbatical

Tesla’s (NASDAQ: TSLA) head of artificial intelligence (AI) Andrej Karpathy is officially leaving the company. On the whole, this information comes directly from Karpathy via a statement yesterday. Karpathy writes, “It’s been a great pleasure to help Tesla towards its goals over the last 5 years and a difficult decision to part ways.” This would be a sizable change for Tesla as Andrej is also among the pioneering leads for Tesla’s Autopilot Vision department. 

He also speaks on this via a Twitter post saying, “In that time, Autopilot graduated from lane keeping to city streets and I look forward to seeing the exceptionally strong Autopilot team continue that momentum.” Also, this news follows the revelation of 229 layoffs within Tesla’s autopilot division after the closing of the company’s San Mateo office. Whether this could translate to further turbulence ahead for TSLA stock remains to be seen.

Source: TradingView

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

By Amos C

Amos is the global markets correspondent for StockMarket.com. His boots on the ground insight into emerging markets has given him the unique ability to stay ahead of new market trends and deliver timely data when it matters most. Based in Asia, Amos has made a point to monitor the foreign markets closely, dissect stock market trends and then apply them to the North American markets; in addition to global markets.

Amos has a deep-rooted background in foreign exchange and commodities. His previous experience working within the cryptocurrency arena has given him the advantage to identify the fast-moving stock market and financial trends. Amos calls Hong Kong home and has been a financial content writer for the last 3 years.

He has managed teams of international media strategists and financial writers to cover all top stories in the stock market each day. His skills include his tireless drive to find the most valid information and actionable details that investors can use to formulate valid decisions on stocks to buy or stocks to avoid. Furthermore, Amos’ ability to cover trending stories across the globe brings StockMarket.com a fresh perspective on key data and how it not only affects the North American markets but also how it could translate to the world markets alike.

Most of the time you can find him diving into corporate filings, focusing on fundamentals that could influence major market moves. One of his passions is researching technology and biotechnology stocks. Some of the most cutting-edge innovations have stemmed from these industries. While many don’t become industry blockbusters, the processes and applications of these innovations has led to some of the biggest developments known to man in the modern age. As a global correspondent, Amos has been able to see both sides of the story as it relates to world news and offers a true, personal approach, cutting through the noise of the mass media. He was integral in reporting on the Hong Kong uprising and doing first-hand research on international sentiment from the novel coronavirus.

In his free time, Amos is an avid fan of music and art and enjoys attending concerts.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments